WST — West Pharmaceutical Services Cashflow Statement
0.000.00%
Last trade - 00:00- $19.46bn
- $19.16bn
- $2.89bn
- 93
- 17
- 74
- 66
Annual cashflow statement for West Pharmaceutical Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 346 | 662 | 586 | 593 | 493 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 33.3 | 36.6 | 59.8 | 28.7 | 5.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.3 | -194 | -11.5 | -20.4 | 2.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 473 | 584 | 724 | 777 | 653 |
| Capital Expenditures | -174 | -253 | -285 | -362 | -377 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.1 | 0.3 | -3.6 | -6.7 | -1.7 |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -180 | -253 | -288 | -369 | -379 |
| Financing Cash Flow Items | — | 0 | -1.2 | -0.1 | -2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -137 | -168 | -294 | -460 | -623 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 176 | 147 | 132 | -40.4 | -369 |